The Effect of Therapeutic Play Applied With Puppet

April 3, 2023 updated by: ARZU SARIALİOĞLU, Ataturk University

The Effect of Therapeutic Play Applied With Puppet During Blood Collection in Children on Pain and Fear

The aim of this study is to determine the effect of therapeutic play applied with a hand puppet during blood collection on pain and fear in children. The project is a randomized controlled trial. The study includes children aged 3-6 years who came to the pediatric blood collection unit of Binali Yıldırım University Mengücek Gazi Training and Research Hospital between 01/07/2022 and 01/01/2023. The research sample; children who apply to the unit on the specified dates and meet the research criteria and volunteer to participate in the research. "Survey Form", "Wong-Baker Evaluation of Facial Expressions Scale" and "Child Fear Scale" will be used in data collection.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Type of Study: The study is a randomized controlled trial. Population and Sample of the Research: The population of the research includes children aged 3-6 years who came to the pediatric blood collection unit of Binali Yıldırım University Mengücek Gazi Training and Research Hospital between 01/07/2022-01/01/2023.

The research sample; "Children who apply to the blood collection unit on the specified dates and meet the research criteria and volunteer to participate in the research". In this study, "prior power analysis" was conducted to determine sample adequacy. In the Priori power analysis, "Cohen's method of reference to standard effect sizes" was chosen. In this case, in our study, the effect of the therapeutic game applied with a hand puppet during blood collection on pain and fear in children will be compared. It has been determined that 80% power can be reached. It was decided to collect data from a total of 100 individuals by including 10% backup sample in this number in case of data loss. Data collection will not be carried out simultaneously in the puppet and control groups, in case the children in the clinic are affected by the puppet toys. In order to ensure randomization, the children who met the criteria will be included in the control group in the first week, and the children who come in the second week will be taken into the puppet group, and this cycle will be continued until the end of the study, and randomization will be ensured.

Data Collection Tools to be Used in the Study: "Survey Form, Wong-Baker Facial Expression Evaluation Scale and Child Fear Scale" will be used to collect research data. As an intervention tool in the research, a hand puppet designed together with the researcher and child development specialist will be used.

Questionnaire Form: In the questionnaire form created by the researchers by scanning the literature; There are questions addressing the introductory characteristics of the research group.

Intervention Tools to be Used in the Research Hand puppet: A hand puppet designed together with the researcher and child development specialist will be used as an intervention tool in the research. In this context, the researcher received play therapy training. While the puppet is being designed, it will be ensured that it is integrated in the hospital environment and it will be ensured that the child is not alienated to the environment he/she comes from. The researcher, who received play therapy training in hand puppet practice, plans to reduce the children's fears and reduce the level of pain before the intervention. While designing the hand puppet, care will be taken to ensure that the materials to be used are antiallergenic and made of fabric that can be easily sterilized after each child the application is made.

Data Collection The researcher will stay in the pediatric blood collection unit for 1 day in order to examine the ergonomic structure of the pediatric blood collection unit before collecting the data of the puppet group and control group children. Parents were informed about the research (the purpose of the research, why the research was conducted, the use of a puppet toy to relieve the child's pain and fear, etc.), after giving verbal consent from the children and written consent from the parents. Afterwards, the data of the research will be obtained by face-to-face interview method with the children who accepted to participate in the research.

Control Group: Questionnaires and scales will be filled in the control group 5 minutes before the blood draw is done by the researcher. Only routine applications will be made. 5 minutes after the procedure, the scales will be filled again. Filling out the forms will take 5-10 minutes on average.

Puppet Group: Questionnaires and scales will be filled in 5 minutes before the blood draw is done by the researcher. It will be played with the puppet during the process. 5 minutes after the procedure, the scales will be filled again. Filling out the forms will take 5-10 minutes on average.

Evaluation of Data The processing and statistical analysis of the collected data will be done with the analysis software called SPSS (Statistical Package for the Social Sciences) for Windows 20.0.

Ethical Principles of Research In order to carry out the research, official permission from the relevant institution will be obtained from the Ethics Committee with ethical approval. Children who meet the criteria of the research group will be informed about the purpose of the study, their questions will be answered, and their verbal and written consent will be obtained. Parents and children will be informed that the data collected during the research will be processed anonymously, confidentially, and will not be used outside of the study in question, and that they can leave the study whenever they wish. Since the research is based on the use of data obtained from humans, and therefore, due to the necessity of observing personal rights, the relevant ethical principles "Informed Consent", "Volunteerism" and "Protection of Confidentiality" will be followed. After the blood collection process is completed, the children in the control group will be played with a puppet and the "Principle of Equality" will be tried to be fulfilled.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Center
      • Erzurum, Center, Turkey, 25240
        • Ataturk University Nursing of Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • be between 3-6 years old
  • Not having a disability related to developmental areas
  • Not taking analgesics within 24 hours before application
  • Being with the mother or father of the child during the procedure

Exclusion Criteria:

  • Not between 3-6 years old
  • Having a disability related to developmental areas
  • Taking analgesics within 24 hours before admission
  • Not being with the mother or father of the child during the procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Puppet
pain and fear
pain and fear during blood collection
No Intervention: control
not pain and fear

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wong-Baker Facial Expression Evaluation Scale (WB-FAI)
Time Frame: 9 MONTHS
The scale was developed in 1981 and was revised in 1983. The scale is used to define pain in the 3-18 age group. The scale indicates that the severity of pain increases from zero to five as you go from left to right. Facial expressions are included under the numbers to describe the severity of pain. It consists of 6 faces in total. While the first smiling facial expression expresses the pain-free state, the crying facial expression at the end indicates the most severe pain intensity. While applying the scale, the child is told to choose the facial expression that best describes his feelings at the moment. Six facial expressions are scored between 0-5 points from left to right (0 points = very happy/no pain, 5 points = indicates the most severe pain). As the score obtained from the scale increases, the pain tolerance decreases, and as the score decreases, the tolerance increases.
9 MONTHS
Child Fear Scale (CFS):
Time Frame: 9 MONTHS
The scale was developed in 2011. The Child Fear Scale is used to determine the level of fear in children undergoing painful medical procedures. The Child Fear Scale is a scale from 0-4 showing five faces ranging from a neutral expression (0 = no worry) to the feared face (4 = serious anxiety).
9 MONTHS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 19, 2022

Primary Completion (Actual)

October 27, 2022

Study Completion (Actual)

December 28, 2022

Study Registration Dates

First Submitted

June 22, 2022

First Submitted That Met QC Criteria

June 27, 2022

First Posted (Actual)

June 29, 2022

Study Record Updates

Last Update Posted (Actual)

April 4, 2023

Last Update Submitted That Met QC Criteria

April 3, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • B.30.2.ATA.0.01.00/449

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

THE ARTICLE IS INTENDED TO BE SHARED AFTER IT IS PUBLISHED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bloodletting

Clinical Trials on puppet

Subscribe